Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Freeman Mason
Relationship:   Chief Medical Officer
City:   Burlington
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   0    

Indirect Shares

  0      
Direct Value   $0    

Indirect Value

  $0      
Total Shares   0      
Total Value   $0      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Scpharmaceuticals Inc. SCPH 0 0    Premium*  
            Cincor Pharma, Inc. CINC Chief Medical Officer 2023-02-24 0 2023-02-24 0    Premium*  
* Premium Members only  

Records found :    7         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CINC Cincor Pharma, Inc. Chief Medical Officer   •       –      –    2023-02-24 4 D $0.00 $0 D/D (2,494) 40,000 0 -
CINC Cincor Pharma, Inc. Chief Medical Officer   •       –      –    2023-02-24 4 D $0.00 $0 D/D (40,000) 0 0 -
CINC Cincor Pharma, Inc. Chief Medical Officer   •       –      –    2023-02-24 4 D $0.00 $0 I/I (100) 0 0 -
CINC Cincor Pharma, Inc. Chief Medical Officer   •       –      –    2023-01-26 4 A $0.00 $0 D/D 40,000 42,500 0 -
CINC Cincor Pharma, Inc. Chief Medical Officer   •       –      –    2022-06-10 4 S $15.21 $91 D/D (6) 2,494 0 -
CINC Cincor Pharma, Inc. EVP Clinical Development   •       –      –    2022-01-11 4 B $16.00 $40,000 D/D 2,500 2,500 2.74 -
CINC Cincor Pharma, Inc. EVP Clinical Development   •       –      –    2022-01-11 4 B $16.00 $1,600 I/I 100 100 1.91 -

  7  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed